Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1993 Sep;46(9):810–816. doi: 10.1136/jcp.46.9.810

Proliferative activity of normal and neoplastic urothelium and its relation to epidermal growth factor and transferrin receptors.

C Limas 1, R Bair 1, P Bernhart 1, P Reddy 1
PMCID: PMC501514  PMID: 8227429

Abstract

AIMS--To investigate the proliferative activity (given by the Ki67 index) of the normal, atypical, and neoplastic urothelium and its relation to the cellular reactivity for the epidermal growth factor (EGFr) and transferrin (Tfr) receptors. METHODS--The Ki67 index and the level of EGFr and Tfr reactivity were determined on frozen sections from 82 patients with urothelial cancer. Relevant clinical material was reviewed to establish correlations with the degree of atypia and invasion. RESULTS--Morphologically normal urothelium, whether derived from controls or patients with cancer, exhibited a low Ki67 index (less than 0.1%) and weak receptor reactivity. In transitional cell carcinomas (TCCs) the Ki67 index was increased: it ranged between 0.7% and 10% in non-invasive and exceeded 10% in 88% of the invasive TCCs. Strong positive reactions for EGFr were seen only in invasive TCCs, but in 47% of invasive TCCs the EGFr was not "overexpressed" and did not match the Ki67 index. A better correlation was found between the Ki67 index and the Tfr which was positive in 26% of the non-invasive and in 71% of the invasive tumours. All three variables were increased in severe atypia but varied considerably in lesser degrees of atypia. CONCLUSIONS--Despite the absence of a close correlation, accelerated growth and enhanced receptor expression were characteristic of invasive cancers. These results suggest that the growth rate in TCCs is not causally related to overexpression of growth factor receptors but that the latter is an abnormality which may accompany the malignant phenotype.

Full text

PDF
810

Images in this article

813Image
on p.813
814Image
on p.814
815Image
on p.815

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown D. C., Gatter K. C. Monoclonal antibody Ki-67: its use in histopathology. Histopathology. 1990 Dec;17(6):489–503. doi: 10.1111/j.1365-2559.1990.tb00788.x. [DOI] [PubMed] [Google Scholar]
  2. Carpenter G., Cohen S. Epidermal growth factor. Annu Rev Biochem. 1979;48:193–216. doi: 10.1146/annurev.bi.48.070179.001205. [DOI] [PubMed] [Google Scholar]
  3. Dubeau L., Jones P. A. Growth of normal and neoplastic urothelium and response to epidermal growth factor in a defined serum-free medium. Cancer Res. 1987 Apr 15;47(8):2107–2112. [PubMed] [Google Scholar]
  4. Gatter K. C., Brown G., Trowbridge I. S., Woolston R. E., Mason D. Y. Transferrin receptors in human tissues: their distribution and possible clinical relevance. J Clin Pathol. 1983 May;36(5):539–545. doi: 10.1136/jcp.36.5.539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gerdes J., Schwab U., Lemke H., Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer. 1983 Jan 15;31(1):13–20. doi: 10.1002/ijc.2910310104. [DOI] [PubMed] [Google Scholar]
  6. Judd W., Poodry C. A., Strominger J. L. Novel surface antigen expressed on dividing cells but absent from nondividing cells. J Exp Med. 1980 Nov 1;152(5):1430–1435. doi: 10.1084/jem.152.5.1430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Koss L. G., Nakanishi I., Freed S. Z. Nonpapillary carcinoma in situ and atypical hyperplasia in cancerous bladders: further studies of surgically removed bladders by mapping. Urology. 1977 Apr;9(4):442–455. doi: 10.1016/0090-4295(77)90227-8. [DOI] [PubMed] [Google Scholar]
  8. Limas C., Bigler A., Bair R., Bernhart P., Reddy P. Proliferative activity of urothelial neoplasms: comparison of BrdU incorporation, Ki67 expression, and nucleolar organiser regions. J Clin Pathol. 1993 Feb;46(2):159–165. doi: 10.1136/jcp.46.2.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Limas C. Relationship of epidermal growth factor receptor detectability with the A, B, H blood group antigens. Emphasis on normal and neoplastic urothelium. Am J Pathol. 1991 Jul;139(1):131–137. [PMC free article] [PubMed] [Google Scholar]
  10. Mellon K., Neal D. E., Robinson M. C., Marsh C., Wright C. Cell cycling in bladder carcinoma determined by monoclonal antibody Ki67. Br J Urol. 1990 Sep;66(3):281–285. doi: 10.1111/j.1464-410x.1990.tb14927.x. [DOI] [PubMed] [Google Scholar]
  11. Messing E. M., Hanson P., Ulrich P., Erturk E. Epidermal growth factor--interactions with normal and malignant urothelium: in vivo and in situ studies. J Urol. 1987 Nov;138(5):1329–1335. doi: 10.1016/s0022-5347(17)43593-2. [DOI] [PubMed] [Google Scholar]
  12. Mulder A. H., Van Hootegem J. C., Sylvester R., ten Kate F. J., Kurth K. H., Ooms E. C., Van der Kwast T. H. Prognostic factors in bladder carcinoma: histologic parameters and expression of a cell cycle-related nuclear antigen (Ki-67). J Pathol. 1992 Jan;166(1):37–43. doi: 10.1002/path.1711660107. [DOI] [PubMed] [Google Scholar]
  13. Neal D. E., Marsh C., Bennett M. K., Abel P. D., Hall R. R., Sainsbury J. R., Harris A. L. Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours. Lancet. 1985 Feb 16;1(8425):366–368. doi: 10.1016/s0140-6736(85)91386-8. [DOI] [PubMed] [Google Scholar]
  14. Smith N. W., Strutton G. M., Walsh M. D., Wright G. R., Seymour G. J., Lavin M. F., Gardiner R. A. Transferrin receptor expression in primary superficial human bladder tumours identifies patients who develop recurrences. Br J Urol. 1990 Apr;65(4):339–344. doi: 10.1111/j.1464-410x.1990.tb14752.x. [DOI] [PubMed] [Google Scholar]
  15. Sufrin G., Meyer J. S., Martin S. A., Schechtman K. Proliferative activity of urothelium and tumors of renal pelvis, ureter, and urinary bladder evaluated by thymidine labeling. Urology. 1984 Mar;23(3 Suppl):15–22. doi: 10.1016/s0090-4295(84)80109-0. [DOI] [PubMed] [Google Scholar]
  16. Sutherland R., Delia D., Schneider C., Newman R., Kemshead J., Greaves M. Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin. Proc Natl Acad Sci U S A. 1981 Jul;78(7):4515–4519. doi: 10.1073/pnas.78.7.4515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Tsujihashi H., Matsuda H., Uejima S., Akiyama T., Kurita T. Cell proliferation of human bladder tumors. J Urol. 1989 Oct;142(4):1113–1116. doi: 10.1016/s0022-5347(17)39008-0. [DOI] [PubMed] [Google Scholar]
  18. Waterfield M. D., Mayes E. L., Stroobant P., Bennet P. L., Young S., Goodfellow P. N., Banting G. S., Ozanne B. A monoclonal antibody to the human epidermal growth factor receptor. J Cell Biochem. 1982;20(2):149–161. doi: 10.1002/jcb.240200207. [DOI] [PubMed] [Google Scholar]
  19. Wood D. P., Jr, Fair W. R., Chaganti R. S. Evaluation of epidermal growth factor receptor DNA amplification and mRNA expression in bladder cancer. J Urol. 1992 Jan;147(1):274–277. doi: 10.1016/s0022-5347(17)37212-9. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES